Developer docs
API playgroundTry for free, no card

Search company profiles

AeroSafe Global

Full company profile

uuid0000od8

Namestring
AeroSafe Global
Legal namestring
AeroSafe Global
Company typeenum
Private
Founded yearint
2014
Short descriptiontext

AeroSafe Global operates a proprietary Cold Chain as a Service (CCaaS) platform combining NASA-derived thermal packaging and AI-enabled delivery intelligence to ship temperature-sensitive pharmaceutical therapies for major manufacturers, distributors, health systems, and specialty pharmacies across 80-85 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersRochester, United States
HQ citystring
Rochester
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cold chain logistics, pharmaceutical distribution, thermal packaging solutions, temperature-controlled shipping, reusable shipping containers
NAICS code3 codes
  • Refrigerated Warehousing and Storage49312
  • Refrigerated Warehousing and Storage493120
  • Air Transportation481
SIC code1 code
  • Air Courier Services4513
Product category
Pharmaceutical Cold Chain Logistics
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Cold Chain as a Service (CCaaS) Subscription
TypeManaged Services
Description

Integrated service model combining reusable thermal packaging assets, logistics management, delivery intelligence technology, and operational support. Customers pay for access to the full ecosystem including container use, recovery logistics, and digital visibility tools. Pricing is typically structured around shipment volume with enterprise contracts for major pharmaceutical manufacturers and health systems.

aerosafeglobal.com
2Per-Shipment Fees
TypeUsage Based
Description

Usage-based revenue from individual shipments transported through the CCaaS network. Volume varies by customer - major partners like BioCareSD move 155,000+ shipments annually through the platform.

aerosafeglobal.com
3Vendor-Managed Inventory Services
TypeManaged Services
Description

AeroSafe manages packaging inventory for customers, eliminating the need for customers to hold excess empty boxes. Reduces customer inventory from 18 months of stock to 1-2 weeks, with AeroSafe handling restocking and logistics.

aerosafeglobal.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1Enterprise contracts with pharmaceutical manufacturers, distributors, and health systems
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Custom pricing based on shipment volume, service tier, and contract length. Typically multi-year agreements with major pharma companies and 200+ health systems.

aerosafeglobal.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1Cold Chain as a Service (CCaaS)
Description

Proprietary end-to-end cold chain delivery model combining advanced thermal technology with AI-powered delivery intelligence

aerosafeglobal.com
+3 more records
Core offering1 text field

AeroSafe Global delivers Cold Chain as a Service (CCaaS): an integrated system of reusable NASA-derived thermal packaging, AI-powered delivery intelligence, and closed-loop return logistics that ensures safe, temperature-controlled delivery of pharmaceutical therapies to manufacturers, distributors, health systems, and specialty pharmacies worldwide. Customers access the full ecosystem — packaging assets, vendor-managed inventory, real-time shipment visibility, predictive risk analytics, and container recovery — under enterprise subscriptions priced by shipment volume.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 10 values shown
  • Zero cold-chain excursions since 2014 across 40+ billion therapies delivered
+9 more records
Product overview1 text field

AeroSafe Global operates a Cold Chain as a Service (CCaaS) model that integrates advanced thermal packaging technology with AI-powered delivery intelligence and a comprehensive full-cycle reuse program. The core CCaaS platform is supported by the Cold Chain on Demand service for end-to-end delivery management and the Delivery Intelligence Navigator platform for AI-enabled predictive visibility and real-time data integration. The Full-Cycle Reuse Parcel Program provides sustainable reusable thermal packaging solutions with industry-leading 98.6% recovery rates. Supporting technologies include AeroVision scanning hardware and the Targeted Risk Improvement Program (TRIP) for continuous optimization.

Product and service5 records
1Cold Chain as a Service (CCaaS)
CategoryCold chain logistics service
Description

End-to-end cold chain delivery ecosystem combining reusable thermal packaging assets, AI-powered delivery intelligence, vendor-managed inventory, and closed-loop return logistics for pharmaceutical manufacturers, distributors, health systems, and specialty pharmacies. Customers access the full ecosystem under enterprise subscription-style contracts priced by shipment volume.

2Cold Chain on Demand
CategoryCold chain delivery management service
Description

End-to-end delivery management service that combines advanced thermal technology with dedicated service oversight to guarantee safe transfer of life-saving medicines; removes operational burden from site personnel and provides personalized customer service and proactive delivery challenge resolution for healthcare systems.

3Delivery Intelligence Navigator
CategoryDelivery intelligence software platform
Description

AI-enabled predictive visibility platform that captures 350+ data points per shipment, integrates real-time carrier signals, calculates thermal load exposure hourly, and shifts operations from reactive troubleshooting to proactive AI-driven risk prevention.

4Full-Cycle Reuse Parcel Program
CategoryReusable thermal packaging service
Description

Closed-loop reusable thermal container program with industry-leading 98.7% recovery rate across 85 countries, 75+ reuses per container (some over 100), eliminating single-use EPS packaging waste and reducing CO2 emissions by 65%.

5AeroVision Scanning System
CategoryLogistics scanning hardware
Description

Hardware technology installed in partner facilities (e.g., on conveyors at MD Logistics warehouses) that scans shippers, captures bin and tracking numbers, and relays data to AeroSafe and manufacturers for real-time temperature, location, and delivery status.

Scale indicator15 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1MD Logistics
Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Strategic partnership with MD Logistics, a third-party logistics provider with three decades of pharmaceutical industry experience. MD Logistics integrates AeroSafe's reusable thermal packaging into their warehouse operations, handling physical logistics while AeroSafe provides technology layer, digital visibility tools (AeroVision), and packaging assets. Partnership enables mutual clients to achieve zero product loss, 65% CO2 reduction, and seamless shipment visibility. MD Logistics reengineered warehouse flows to accommodate AeroSafe's reusable shippers and installed AeroVision scanning hardware on conveyors.

aerosafeglobal.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Sonoco's ThermoSafe division is the largest direct competitor in temperature-controlled pharmaceutical packaging, offering both passive and active reusable containers across global life sciences logistics — overlapping directly with AeroSafe's reusable shipper fleet and CCaaS positioning.

2Pelican BioThermal
TypeDirect peer
Description

Pelican BioThermal offers reusable and single-use temperature-controlled shippers (Credo series) for pharma and biologics with similar payload profiles and duration claims to AeroSafe's NASA-derived containers, competing head-to-head for the same pharmaceutical manufacturer customers.

TypeDirect peer
Description

CSafe Global manufactures active and passive temperature-controlled shipping containers for pharmaceuticals, with a comparable focus on biologics and high-value therapies — directly competitive with AeroSafe on container performance and pharma customer wins.

TypeDirect peer
Description

Cryoport provides integrated temperature-controlled supply chain solutions for the life sciences industry, combining cryogenic logistics, packaging, and chain-of-custody technology — directly comparable to AeroSafe's CCaaS model for high-value, temperature-sensitive therapies.

TypeDirect peer
Description

va-Q-tec manufactures high-performance vacuum insulation panel (VIP) containers for pharmaceutical cold chain shipping, with reusable container programs and global service similar to AeroSafe's full-cycle reuse model.

TypeBroad incumbent
Description

World Courier, owned by Cencora (a current AeroSafe customer), provides specialty pharmaceutical logistics and cold chain distribution globally. As a Cencora partner, AeroSafe could face competitive overlap if Cencora internalizes or consolidates cold chain services.

TypeBroad incumbent
Description

Marken, part of UPS Healthcare, offers global temperature-controlled clinical trial and commercial pharmaceutical logistics with strong carrier-backed scale — a broader incumbent that competes with AeroSafe in life sciences cold chain delivery.

8FedEx Custom Critical
TypeBroad incumbent
Description

FedEx Custom Critical provides time- and temperature-sensitive shipping with extensive North American air and ground capacity — a large incumbent that competes for premium cold chain pharma shipments, though without AeroSafe's reusable asset model.

TypeBroad incumbent
Description

DHL Supply Chain's Life Sciences division provides global cold chain warehousing and transportation with extensive GDP-compliant infrastructure, competing for the same enterprise pharmaceutical manufacturers as AeroSafe.

TypeEmerging player
Description

BioLife Solutions provides biopreservation tools and cold chain solutions for cell and gene therapies — adjacent to AeroSafe's specialty pharma cold chain focus, with overlap in high-value biologic shipping but a narrower product line.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers15 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds13 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors13 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AeroSafe Global

Pharmaceutical Cold Chain Logisticsaerosafeglobal.com

AeroSafe Global operates a proprietary Cold Chain as a Service (CCaaS) platform combining NASA-derived thermal packaging and AI-enabled delivery intelligence to ship temperature-sensitive pharmaceutical therapies for major manufacturers, distributors, health systems, and specialty pharmacies across 80-85 countries.

AeroSafe Global firmographics

Firmographics
Name
AeroSafe Global
Legal name
AeroSafe Global
Website
https://aerosafeglobal.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
101–250 employees
Short description
AeroSafe Global operates a proprietary Cold Chain as a Service (CCaaS) platform combining NASA-derived thermal packaging and AI-enabled delivery intelligence to ship temperature-sensitive pharmaceutical therapies for major manufacturers, distributors, health systems, and specialty pharmacies across 80-85 countries.
Ownership category
akta.pro rank

Where AeroSafe Global is headquartered

Location

Headquarters

HQ city
Rochester
HQ country
United States
HQ region
North America

Offices3 records

Markets served

AeroSafe Global business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Cold Chain as a Service (CCaaS) Subscription: Integrated service model combining reusable thermal packaging assets, logistics management, delivery intelligence technology, and operational support. Customers pay for access to the full ecosystem including container use, recovery logistics, and digital visibility tools. Pricing is typically structured around shipment volume with enterprise contracts for major pharmaceutical manufacturers and health systems.
  2. Per-Shipment Fees: Usage-based revenue from individual shipments transported through the CCaaS network. Volume varies by customer - major partners like BioCareSD move 155,000+ shipments annually through the platform.
  3. Vendor-Managed Inventory Services: AeroSafe manages packaging inventory for customers, eliminating the need for customers to hold excess empty boxes. Reduces customer inventory from 18 months of stock to 1-2 weeks, with AeroSafe handling restocking and logistics.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractEnterprise contracts with pharmaceutical manufacturers, distributors, and health systems

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

AeroSafe Global product offering

Product offering

Core offering

AeroSafe Global delivers Cold Chain as a Service (CCaaS): an integrated system of reusable NASA-derived thermal packaging, AI-powered delivery intelligence, and closed-loop return logistics that ensures safe, temperature-controlled delivery of pharmaceutical therapies to manufacturers, distributors, health systems, and specialty pharmacies worldwide. Customers access the full ecosystem — packaging assets, vendor-managed inventory, real-time shipment visibility, predictive risk analytics, and container recovery — under enterprise subscriptions priced by shipment volume.

Product overview

AeroSafe Global operates a Cold Chain as a Service (CCaaS) model that integrates advanced thermal packaging technology with AI-powered delivery intelligence and a comprehensive full-cycle reuse program. The core CCaaS platform is supported by the Cold Chain on Demand service for end-to-end delivery management and the Delivery Intelligence Navigator platform for AI-enabled predictive visibility and real-time data integration. The Full-Cycle Reuse Parcel Program provides sustainable reusable thermal packaging solutions with industry-leading 98.6% recovery rates. Supporting technologies include AeroVision scanning hardware and the Targeted Risk Improvement Program (TRIP) for continuous optimization.

Differentiator

Problem solved

Functional benefit

Brands

  • Cold Chain as a Service (CCaaS): Proprietary end-to-end cold chain delivery model combining advanced thermal technology with AI-powered delivery intelligence
  • Cold Chain on Demand
  • Delivery Intelligence Navigator
  • Full-Cycle Reuse Program

Products and services

  • Cold Chain as a Service (CCaaS) End-to-end cold chain delivery ecosystem combining reusable thermal packaging assets, AI-powered delivery intelligence, vendor-managed inventory, and closed-loop return logistics for pharmaceutical manufacturers, distributors, health systems, and specialty pharmacies. Customers access the full ecosystem under enterprise subscription-style contracts priced by shipment volume.
  • Cold Chain on Demand End-to-end delivery management service that combines advanced thermal technology with dedicated service oversight to guarantee safe transfer of life-saving medicines; removes operational burden from site personnel and provides personalized customer service and proactive delivery challenge resolution for healthcare systems.
  • Delivery Intelligence Navigator AI-enabled predictive visibility platform that captures 350+ data points per shipment, integrates real-time carrier signals, calculates thermal load exposure hourly, and shifts operations from reactive troubleshooting to proactive AI-driven risk prevention.
  • Full-Cycle Reuse Parcel Program Closed-loop reusable thermal container program with industry-leading 98.7% recovery rate across 85 countries, 75+ reuses per container (some over 100), eliminating single-use EPS packaging waste and reducing CO2 emissions by 65%.
  • AeroVision Scanning System Hardware technology installed in partner facilities (e.g., on conveyors at MD Logistics warehouses) that scans shippers, captures bin and tracking numbers, and relays data to AeroSafe and manufacturers for real-time temperature, location, and delivery status.

Quantifiable outcome

  • Zero cold-chain excursions since 2014 across 40+ billion therapies delivered
  • +9 more outcomes

Companies that use AeroSafe Global

Customer profile

Named customers15 records

Segments5 records

Ideal customer profiles4 records

AeroSafe Global technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

AeroSafe Global partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • MD LogisticscoreImplementation/ SI/ Consulting PartnerStrategic partnership with MD Logistics, a third-party logistics provider with three decades of pharmaceutical industry experience. MD Logistics integrates AeroSafe's reusable thermal packaging into their warehouse operations, handling physical logistics while AeroSafe provides technology layer, digital visibility tools (AeroVision), and packaging assets. Partnership enables mutual clients to achieve zero product loss, 65% CO2 reduction, and seamless shipment visibility. MD Logistics reengineered warehouse flows to accommodate AeroSafe's reusable shippers and installed AeroVision scanning hardware on conveyors.

Scale indicators15 records

Recent moves6 records

Expansion highlights6 records

AeroSafe Global competitors and assessment

Company assessment

Direct peers

  • Sonoco ThermoSafe: Sonoco's ThermoSafe division is the largest direct competitor in temperature-controlled pharmaceutical packaging, offering both passive and active reusable containers across global life sciences logistics — overlapping directly with AeroSafe's reusable shipper fleet and CCaaS positioning.
  • Pelican BioThermal: Pelican BioThermal offers reusable and single-use temperature-controlled shippers (Credo series) for pharma and biologics with similar payload profiles and duration claims to AeroSafe's NASA-derived containers, competing head-to-head for the same pharmaceutical manufacturer customers.
  • CSafe Global: CSafe Global manufactures active and passive temperature-controlled shipping containers for pharmaceuticals, with a comparable focus on biologics and high-value therapies — directly competitive with AeroSafe on container performance and pharma customer wins.
  • Cryoport (now SK Pharmteco subsidiary): Cryoport provides integrated temperature-controlled supply chain solutions for the life sciences industry, combining cryogenic logistics, packaging, and chain-of-custody technology — directly comparable to AeroSafe's CCaaS model for high-value, temperature-sensitive therapies.
  • va-Q-tec: va-Q-tec manufactures high-performance vacuum insulation panel (VIP) containers for pharmaceutical cold chain shipping, with reusable container programs and global service similar to AeroSafe's full-cycle reuse model.

Broad incumbents

  • World Courier (Cencora): World Courier, owned by Cencora (a current AeroSafe customer), provides specialty pharmaceutical logistics and cold chain distribution globally. As a Cencora partner, AeroSafe could face competitive overlap if Cencora internalizes or consolidates cold chain services.
  • Marken (UPS Healthcare): Marken, part of UPS Healthcare, offers global temperature-controlled clinical trial and commercial pharmaceutical logistics with strong carrier-backed scale — a broader incumbent that competes with AeroSafe in life sciences cold chain delivery.
  • FedEx Custom Critical: FedEx Custom Critical provides time- and temperature-sensitive shipping with extensive North American air and ground capacity — a large incumbent that competes for premium cold chain pharma shipments, though without AeroSafe's reusable asset model.
  • DHL Life Sciences & Healthcare: DHL Supply Chain's Life Sciences division provides global cold chain warehousing and transportation with extensive GDP-compliant infrastructure, competing for the same enterprise pharmaceutical manufacturers as AeroSafe.

Emerging players

  • BioLife Solutions: BioLife Solutions provides biopreservation tools and cold chain solutions for cell and gene therapies — adjacent to AeroSafe's specialty pharma cold chain focus, with overlap in high-value biologic shipping but a narrower product line.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

AeroSafe Global social profiles

Digital presence

AeroSafe Global financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AeroSafe Global leadership team

Management profile

Number of profiles

Profiles3 records

AeroSafe Global funding detail

Funding detail

Funding overview

Funding rounds13 records

Investors13 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AeroSafe Global M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AeroSafe Global

What does AeroSafe Global do?

AeroSafe Global delivers Cold Chain as a Service (CCaaS): an integrated system of reusable NASA-derived thermal packaging, AI-powered delivery intelligence, and closed-loop return logistics that ensures safe, temperature-controlled delivery of pharmaceutical therapies to manufacturers, distributors, health systems, and specialty pharmacies worldwide. Customers access the full ecosystem — packaging assets, vendor-managed inventory, real-time shipment visibility, predictive risk analytics, and container recovery — under enterprise subscriptions priced by shipment volume.

Is AeroSafe Global a public or private company?

AeroSafe Global is a private company. It is classified as venture growth investor backed and is currently operating.

When was AeroSafe Global founded?

AeroSafe Global was founded in 2014. It employs 101 to 250 people.

Where is AeroSafe Global based?

AeroSafe Global is headquartered in Rochester, United States, in the North America region.

How does AeroSafe Global make money?

Three revenue lines are on record. Cold Chain as a Service (CCaaS) Subscription is the primary driver. The others are per-Shipment Fees and vendor-Managed Inventory Services.

Who are AeroSafe Global's main competitors?

Direct peers on record are Sonoco ThermoSafe, Pelican BioThermal, CSafe Global, Cryoport (now SK Pharmteco subsidiary) and va-Q-tec. Broad incumbents are World Courier (Cencora), Marken (UPS Healthcare), FedEx Custom Critical and DHL Life Sciences & Healthcare. BioLife Solutions is listed as an emerging player.

Does AeroSafe Global have an API?

No public API is recorded for AeroSafe Global.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Third NewsAeroSafe Global Achieves Impressive Ranking on Rochester Chamber Top 100 ListAeroSafe Global ranked #7 on the Greater Rochester Chamber's Top 100 list for 2026, highlighting its Cold-Chain-as-a-Service for pharmaceuticals. The company manages 11 million shipments annually across 80 countries and has protected over 40 billion therapies. It is seeking new talent for continued growth.PR NewswireAeroSafe Global Named to Greater Rochester Chamber Top 100 ListAeroSafe Global was named #7 on the Greater Rochester Chamber of Commerce's Top 100 list of fastest-growing privately owned companies. The company provides cold-chain logistics for pharmaceuticals, delivering over 40 billion life-saving therapies with a zero-failure model. It is seeking new hires as it continues to scale.PR NewswireAeroSafe Global Convenes Healthcare Leaders to Address Pharmaceutical Cold-Chain Waste at Sustainability Symposium 2026AeroSafe Global will host a virtual Sustainability Symposium on November 10, 2026, to address pharmaceutical cold-chain waste. The event highlights reusable packaging models that can cut landfill waste by up to 95% and examines closed-loop systems for 70+ turn cycles.RbjAeroSafe Global turns sustainable healthcare logistics into growthRochester-based AeroSafe Global, formerly American Aerogel, has grown into a leading biopharmaceutical supply chain innovator with its proprietary "Cold-Chain-as-a-Service" model operating in more than 80 countries. The company completed a $43 million growth equity round in 2023 and reports that its reusable shipping systems reduce carbon emissions by 65% and landfill waste by 90% compared with single-use packaging, with over half of U.S. healthcare providers now enrolled in its program. CEO Jay McHarg was named an EY Entrepreneur of the Year 2026 New York Award winner and sees future growth opportunities in direct-to-consumer healthcare, artificial intelligence, and enhanced digital services.Third NewsAeroSafe Global CEO Jay McHarg: Winner of EY Entrepreneur Of The Year 2026 New York AwardJay McHarg, CEO of AeroSafe Global, has been awarded the EY Entrepreneur Of The Year 2026 New York Award by Ernst & Young LLP, recognizing his leadership and vision in the biopharmaceutical supply chain industry. Under his leadership, AeroSafe Global has developed a Cold-Chain-as-a-Service model combining NASA-grade thermal technology and AI solutions, operating across more than 80 countries. McHarg's recognition positions him for consideration at the national level, where the Entrepreneur Of The Year National Awards will be announced in November 2026.PR NewswireAeroSafe Global CEO Jay McHarg Named EY Entrepreneur Of The Year® 2026 New York Award WinnerErnst & Young LLP has named Jay McHarg, CEO of AeroSafe Global, as an EY Entrepreneur Of The Year 2026 New York Award winner, recognizing his strategic leadership in building a company that has revolutionized the biopharmaceutical supply chain through its proprietary Cold-Chain-as-a-Service model. AeroSafe Global, headquartered in Rochester, New York, operates across more than 80 countries providing temperature-sensitive therapy delivery with AI-driven technology while reducing carbon emissions by 65%. McHarg will now advance to consideration for the National Awards to be announced in November 2026.AijournAeroSafe Global CEO Jay McHarg Named a Finalist for EY Entrepreneur Of The Year® 2026 New York ProgramAeroSafe Global CEO Jay McHarg has been named a finalist for the EY Entrepreneur Of The Year 2026 New York program, a prestigious business awards competition that honors visionary entrepreneurs who disrupt markets and create long-term value. The company, headquartered in Rochester, New York, operates a "Cold-Chain-as-a-Service" model serving pharmaceutical logistics across 85 countries with capacity for 11 million shipments annually. Regional winners will be announced on June 16, 2026, with those winners advancing to consideration for the national awards in November.PR NewswireAeroSafe Global CEO Jay McHarg Named a Finalist for EY Entrepreneur Of The Year® 2026 New York ProgramAeroSafe Global CEO Jay McHarg has been named a finalist for the EY Entrepreneur Of The Year® 2026 New York Program, a prestigious business awards program recognizing visionary leaders. The announcement highlights McHarg's 30-year track record in strategic and operational leadership and his role in pioneering AeroSafe Global's 'Cold-Chain-as-a-Service' model for pharmaceutical logistics. Regional winners will be announced on June 16, 2026, with national awards following in November.RbjRIT announces 2026 Herbert W. Vanden Brul Award winnerJay McHarg, CEO of AeroSafe Global, was named the 2026 Herbert W. Vanden Brul Entrepreneurial Award winner, to be honored at a luncheon on June 11. The award recognizes regional entrepreneurs who enhance the economy through innovative leadership. McHarg's company provides Cold-Chain-as-a-Service for temperature-sensitive therapies.AxiosScoop: PE-backed AeroSafe Global hires JPM for saleAeroSafe Global, a NewSpring Capital-backed healthcare logistics company, has engaged JPMorgan as a financial advisor to explore a potential sale, as exclusively reported by Axios Pro. This move aligns with broader industry trends of increased investment in health supply chain infrastructure by major shipping and logistics companies. The engagement signals potential M&A activity in the healthcare logistics sector.